In the subcutaneous injection model, co‐injection with vWF‐SAM‐sEV‐treated HUVECs accelerated the tumor development of control PLC/PRF/5 shCTL cells but showed no effect on FGFR knockdown cells (Figure 6F,G). Here, VWF is linked to neoplasm.